Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Drug Delivery: Active Transdermal Delivery Systems' returned 105 results - Page 1 of 6  FEATURED RESULTS Innovation in Drug Delivery: The Future of Nanotechnology an... Cardiovascular Drug Delivery - Technologies, Markets and Com... Drug Delivery in Cancer - Technologies, Markets and Companies Evolving Approaches for Protein Drug Delivery Pulmonary Drug Delivery Technologies - Global Strategic Busi...   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Active Transdermal Delivery Systems: Evolving Technology, Expanding Opportunities   Greystone Associates, Feb 2011 transdermal systems on drug delivery markets - Provides forecasts of active transdermal delivery by market segment to 2014 - Profiles active transdermal system market participants, their technology, product Transdermal Pain Management to 2015: Markets, Demand Factors, Opportunities and Forecasts   Greystone Associates, Dec 2010 vs Active Delivery Systems - Transdermal Pain Management Gels - Transdermal Formulations - IP and Proprietary Technology - Limitations of Topical Gels Transdermal Pain Management Product Assessments The Top 50 Transdermal Drug Delivery Technology Companies Worldwide   Research Facts Ltd, Jan 2011, Pages: 142 drugs in a single patch to the skin. The US Food and Drug Administration (FDA) approved the first transdermal patch products in 1981. These delivery systems provided the controlled systemic absorption Transdermal CNS Therapeutics: Products, Pipeline Candidates, Markets, Forecasts   Greystone Associates, June 2011 and Packaging - The Patch Manufacturing Ecosystem - CNS Patch Economics - Passive vs Active Delivery Systems The Global Market for Transdermal CNS Therapeutics –Disease Segment Analysis - ADHD - Alzheimer Prescription Drug Patches to 2015: Products, Indications, Markets and Opportunities   Greystone Associates, Aug 2011 Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Advances in synthetic Next Generation Transdermal Drug Patches: Evolving Technology, Emerging Opportunities   Greystone Associates, Aug 2011 Nitroglycerin Norelgestromin Oxybutynin Rivastigmine Rotigotine (EU) Scopolamine Selegiline Testosterone Drugs in Development for Transdermal Patch Delivery Systems Antivirals CNS Hormones Metabolic Pain Drug Delivery Technologies - Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies   Arrowhead Publishers, Sep 2008, Pages: 283 .5 TRANSDERMAL DRUG DELIVERY 2.5.1 Passive Formulations 2.5.2 Active Formulations 2.6 NICHE TECHNOLOGIES 2.6.1 Topical Systems 2.6.2 Gene Delivery 2.6.3 Implantable Systems 2.6.4 Drug Delivery Microchips 2 Drug Delivery in Cancer - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 639 vessels Targeted drug delivery of anticancer agents with controlled activation Targeted delivery of anticancer agents with ReCODE™ technology Transmembrane Carrier Systems Transferrin-oligomers Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 345 The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders. Drugs may be administered directly into the CNS or administered systematically (e Iontophoresis Drug Delivery: Devices, Drugs and Therapeutic Prospects   Greystone Associates, May 2011 To expand the limits of transdermal drug delivery, developers are employing energy sources such as ultrasound, heat and electrical current to affect active transport through the skin Nanobiotechnology Applications, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 772 penetration is improved in transdermal drug delivery. A particularly effective application is as nonviral gene therapy vectors. Nanotechnology has the potential to provide controlled release devices Drug Self-Administration Markets to 2016   Greystone Associates, Jan 2012 of the digestive tract, the recent escalation in new biological drugs, including antibodies and recombinant proteins, is placing renewed emphasis on alternate delivery technologies. Now a number of factors Cardiovascular Drug Delivery - Technologies, Markets and Companies   Jain PharmaBiotech, Feb 2012, Pages: 264 Drug delivery to the cardiovascular system is different from delivery to other systems because of the anatomy and physiology of the vascular system; it supplies blood and nutrients to all organs Insulin Patch Pumps: Devices, Markets, Players and Prospects   Greystone Associates, Nov 2011 a transdermal drug device format with an active delivery technology. Provider organization business managers, healthcare administrators and investors will also benefit from this study. Executive Summary The Top 40 Transdermal Drug Delivery Technology Companies Worldwide   Research Facts Ltd, July 2009, Pages: 98 The US Food and Drug Administration (FDA) approved the first transdermal patch products in 1981. These delivery systems provided the controlled systemic absorption of scopolamine for the prevention Drug Delivery Systems: US Market Outlook, Advances for Pharma, Biotech & Medical Devices   Takeda Pacific, Sep 2006, Pages: 163 tablets and filmstrips, needle- and needle-free injection systems, transdermal patches, transmucosal delivery, RNAi, drug-coated stents, PEG, nanotechnology, liposomes, monoclonal antibodies, gene delivery Transdermal Skin Patches: Markets and Opportunities 2009   Greystone Associates, March 2009, Pages: 180 - Testosterone - Varenicline Drugs in Development for Transdermal Patch Delivery Systems - Acyclovir - Bupivacaine - Buprenorphine - Clomiphene - Capsaicin - Declofenac - Dexamethasone - Donepezil - Fentanyl The Global Drug Delivery Market - Research Trends and Market Outlook   Arrowhead Publishers, May 2006, Pages: 233 .4.3 Rectal 2.4.4 Vaginal 2.5 Transdermal Drug Delivery 2.5.1 Passive Formulations 2.5.2 Active Formulations 2.6 Niche Technologies 2.6.1 Topical Systems 2.6.2 Gene Delivery 2.6.3 Implantable Systems 2.6.4 Drug Drug Delivery Innovations Driving Improved Patient Compliance   Business Insights, July 2011, Pages: 147 technologies for sustained release Microcrystallization Liposomes Modified release nasal delivery Advances in transdermal and cutaneous delivery systems Modification of the drug or drug delivery vehicle Leading Drug Delivery Companies and Technologies: Competitive Landscape, Company Profiles and Technological Developments   Business Insights, May 2008, Pages: 175 companies. - Identify the dynamics of major drug delivery systems by evaluating the latest market developments and technological innovations in oral, pulmonary, injectable and transdermal delivery platforms Results:  First -   Prev -   1 -   2 -   3 -   4 -   5 -   6 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network